Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Velan Capital Investment Management LP
Form 13F · Q2 2026

Velan Capital Investment Management LP

CIK 1848809申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$1.6亿
申报组合市值
53
持仓数量
12
Quarters on record
Top 50
持仓数量

Velan Capital Investment Management LP——持仓

共 53 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1PRAX Praxis Precision Medicines I88,781−11.9%$2972万18.1%
2MPLT Maplight Therapeutics Inc492,893+0.0%$1767万10.8%
3STRO Sutro Biopharma Inc512,160+0.0%$1700万10.4%
4IMMX Immix Biopharma Inc1.1M+46.6%$1119万6.8%
5TARA Protara Therapeutics Inc2.8M+0.4%$1087万6.6%
6ABVX Abivax Sa65,630−14.8%$875万5.3%
7TENX Tenax Therapeutics Inc549,985−5.7%$800万4.9%
8AVR Anteris Technologies Global700,000+0.0%$690万4.2%
9EDSA Edesa Biotech Inc827,500+0.0%$673万4.1%
10EVMN Evommune Inc451,255+1.1%$600万3.7%
11AVTX Avalo Therapeutics Inc324,452+75.3%$600万3.7%
12XNCR Xencor Inc255,000+2.0%$411万2.5%
13RZLT Rezolute Inc750,000+0.0%$390万2.4%
14HRTX Heron Therapeutics Inc8.8M+0.0%$374万2.3%
15VRCA Verrica Pharmaceuticals Inc471,559+0.0%$289万1.8%
16CCCC C4 Therapeutics Inc570,000—$266万1.6%
17EPRX Eupraxia Pharmaceuticals Inc352,000+0.0%$233万1.4%
18ADMA Adma Biologics Inc250,000—$209万1.3%
19RNTX Rein Therapeutics Inc1.7M—$177万1.1%
20LYEL Lyell Immunopharma Inc105,000+2.9%$148万0.9%
21NSRX Nasus Pharma Ltd359,390+0.0%$126万0.8%
22PROF Profound Med Corp170,278−40.4%$113万0.7%
23JSPR Jasper Therapeutics Inc2.7M+0.0%$112万0.7%
24PTGX Protagonist Therapeutics Inc3,700+0.0%$45万0.3%
25CTMX Cytomx Therapeutics Inc.120,000−77.8%$45万0.3%
26NMRA Neumora Therapeutics Inc.230,000+187.5%$39万0.2%
27NRIX Nurix Therapeutics Inc16,000+0.0%$39万0.2%
28OVID Ovid Therapeutics Inc130,000−18.8%$35万0.2%
29DTIL Precision Biosciences Inc40,000+0.0%$31万0.2%
30MLYS Mineralys Therapeutics Inc11,000+0.0%$30万0.2%
31MGNX Macrogenics Inc60,000+100.0%$28万0.2%
32CRBP Corbus Pharmaceuticals Hldgs26,000+0.0%$24万0.1%
33ARTV Artiva Biotherapeutics Inc25,000+0.0%$24万0.1%
34REPL Replimune Group Inc20,000+0.0%$22万0.1%
35SNDX Syndax Pharmaceuticals Inc10,000+0.0%$22万0.1%
36IMNM Immunome Inc10,000+0.0%$21万0.1%
37TECX Tectonic Therapeutic Inc6,000—$21万0.1%
38RCKT Rocket Pharmaceuticals Inc60,000−79.6%$21万0.1%
39KPTIQ Karyopharm Therapeutics Inc20,000+33.3%$20万0.1%
40ANTX An2 Therapeutics Inc40,000—$19万0.1%
41VRDN Viridian Therapeutics Inc10,000−89.0%$18万0.1%
42SCYX Scynexis Inc40,000—$16万0.1%
43QNRX Quoin Pharmaceuticals Ltd32,372−61.8%$16万0.1%
44XLO Xilio Therapeutics Inc14,285+0.0%$14万0.1%
45NSPR Inspiremd Inc148,138−92.9%$10万0.1%
46KLRS Kalaris Therapeutics Inc25,000+38.9%$10万0.1%
47LRMR Larimar Therapeutics Inc33,000+0.0%$10万0.1%
48PRQR Proqr Thrapeutics N V45,000+0.0%$8万0.1%
49CNTX Context Therapeutics Inc59,700−40.3%$3万0.0%
50GOSS Gossamer Bio Inc70,000+0.0%$1万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。